3-Heptanone as a potential new marker for valproic acid therapy.


Breath gas samples from 27 patients with epilepsy (17 male and 10 female patients; mean age: 9.7 years, median age: 8.2 years, SD: ±4.2 years) were screened via proton transfer reaction mass spectrometry. The patients were treated with valproic acid (VPA) therapy, and blood samples for determination of VPA concentrations were surveyed. All patients showed… (More)
DOI: 10.1088/1752-7155/3/1/016004

6 Figures and Tables


  • Presentations referencing similar topics